Could DNDN add any changes to the overall picture within the amendment such as asking for wider labling from the successful conclusions from trials like P-11?
In other words, could DNDN get to the same point of expanding the use of Provenge by using just the amendment process? Or do you expect that they will amend the existing BLA in the interim with P-11 results just to get that utility/benefit established?
News 
Market Data 
Discover 
